Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma

Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma ( Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain )
16 Jun 2018

EHA 2018: Research, collaboration and working towards cures

Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland
EHA 2018: Research, collaboration and working towards cures ( Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland )
16 Jun 2018

Educational focus on immunotherapy at EHA

Prof John Gribben - Barts Cancer Institute, London, United Kingdom
Educational focus on immunotherapy at EHA ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018

ADC polatuzumab vedotin in combinations for relapsed lymphoma

Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada
ADC polatuzumab vedotin in combinations for relapsed lymphoma ( Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada )
16 Jun 2018

iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece )
16 Jun 2018

EHA 2018: Initial results of the INSIGHT trial in multiple myeloma

Prof Efstathios Kastritis and Dr Zhengzheng Fu
EHA 2018: Initial results of the INSIGHT trial in multiple myeloma ( Prof Efstathios Kastritis and Dr Zhengzheng Fu )
16 Jun 2018

A new anti-CD22 CAR T immunotherapy for paediatric leukaemia

Dr Jing Pan - Beijing Boren Hospital, Beijing, China
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia ( Dr Jing Pan - Beijing Boren Hospital, Beijing, China )
16 Jun 2018

EHA Topics in focus : Immunotherapy

Prof John Gribben - Barts Cancer Institute, London, United Kingdom
EHA Topics in focus : Immunotherapy ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018

Novel ADC for relapsed/refractory lymphoma

Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada
Novel ADC for relapsed/refractory lymphoma ( Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada )
16 Jun 2018

iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece )
16 Jun 2018

EHA 2018: The unmet needs in maintenance therapy for multiple myeloma

Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma ( Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng )
15 Jun 2018

EHA 2018: Results of the OPTIMISMM trial

Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
EHA 2018: Results of the OPTIMISMM trial ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
15 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation